How tracking early childhood language development could shape future medicine
Source PublicationDevelopmental Science
Primary AuthorsEllwood‐Lowe, Nishio, Dufford et al.
"Think of the brain like wet clay. When we are young, the clay is soft and easy to mould into different shapes, which is how we learn words and grammar. As we grow, the clay slowly dries and hardens. Children who learn language exceptionally well seem to have clay that stays wet just a little bit longer."
For decades, progress in treating complex neurodevelopmental conditions has faced a major hurdle. Doctors struggle to measure exactly how malleable the brain is at any given moment, or how well it might respond to future interventions. We need better ways to track brain plasticity in living patients. A recent neuroimaging study exploring a completely different field might offer a solution, paving the way for the next generation of genomic medicine.
Tracking early childhood language development
Researchers wanted to understand how our brains learn words and grammar. They looked at brain scans from two large neuroimaging datasets of children aged ten months to eighteen years. The team measured something called the Hurst exponent. You can think of this as a radar for brain flexibility. It measures how much the brain is inhibiting new connections.
During early childhood language development, the brain goes through cascading sensitive periods. The study measured how different brain areas change over time. Deep brain regions, like the thalamus, settle into a rigid state quite early. However, the outer layers of the brain stay flexible for much longer. The researchers noted that this cortical flexibility plateaus around age nine. This might explain why older children find it harder to learn complex grammar rules.
Interestingly, the study measured a distinct pattern in children with excellent language skills. Their brains showed a slower increase in the Hurst exponent. This suggests their brains stay flexible for a longer period, allowing them to absorb more information.
Future drug discovery programmes for genomic medicine
This imaging tool does more than explain how we learn to speak. It offers a clear way to measure brain plasticity in living patients. This brings us back to the future of genomic medicine and neurological therapies.
Imagine a new genomic treatment designed to reopen a window of brain plasticity to help treat developmental delays or aid recovery from neurological injury. Right now, testing such an intervention is difficult. Doctors have to wait months or years to observe changes in patient behaviour. But with this new imaging method, future drug discovery programmes could measure success on a structural level much sooner.
Scientists could scan a patient before and after treatment. If the medicine works, the Hurst exponent might show the brain becoming flexible again. The treatment could encourage the brain to re-enter a sensitive period, similar to what we see in young children. This would allow the brain to rewire itself and build new neural pathways.
While the current study focuses on healthy children, the technology points toward a brighter future. By learning how to track flexibility, we can design better genomic medicines. We can finally build effective treatments that harness the brain's natural ability to heal and adapt.